Patents by Inventor Lin Kang

Lin Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170002322
    Abstract: Provided herein are methods of producing natural killer cells using a two-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising administering the NK cells produced by the method to an individual having the cancer or viral infection.
    Type: Application
    Filed: September 12, 2016
    Publication date: January 5, 2017
    Applicant: Anthrogenesis Corporation
    Inventors: Robert J. HARIRI, Mohammad A. HEIDARAN, Stephen JASKO, Lin KANG, Eric LAW, Ajai PAL, Bhavani STOUT, Vanessa VOSKINARIAN-BERSE, Andrew ZEITLIN, Xiaokui ZHANG
  • Publication number: 20160362659
    Abstract: Provided herein are methods of producing erythrocytes from hematopoietic cells, particularly hematopoietic cells from placental perforate in combination with hematopoietic cells from umbilical cord blood, wherein the method results in accelerated expansion and differentiation of the hematopoietic cells to more efficiently produce administrate erythrocytes. Further provided herein is a bioreactor in which hematopoietic cell expansion and differentiation takes place.
    Type: Application
    Filed: December 22, 2015
    Publication date: December 15, 2016
    Applicant: Anthrogenesis Corporation
    Inventors: Stewart Abbot, Lin Kang, Vanessa Voskinarian-Berse, Xiaokui Zhang
  • Publication number: 20160320040
    Abstract: A light-emitting knob assembly is disclosed. The light-emitting knob assembly is disposed on a device for providing a heat source or a fire and includes a knob, a light-sensing plate, an axial bush, a base, and a light generating unit. The knob is utilized for being rotated to control the strength of the heat source or the strength of the fire of the device and driving the light-sensing plate and the axial bush to be rotated relative to the light generating unit. The light generating unit generates different brightnesses and/or different colors of lights to correspondingly display the strength of the heat source or the strength of the fire after the light-sensing plate is rotated. A user can distinguish the strength of the heat source or the strength of the fire via the light-emitting knob assembly from a distance.
    Type: Application
    Filed: April 27, 2016
    Publication date: November 3, 2016
    Inventors: Chi-Lin KANG, Jian-jou CHAN, Chung-Hsin HSIEH
  • Patent number: 9464274
    Abstract: Provided herein are methods of producing natural killer cells using a two-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising administering the NK cells produced by the method to an individual having the cancer or viral infection.
    Type: Grant
    Filed: November 18, 2014
    Date of Patent: October 11, 2016
    Assignee: Anthrogenesis Corporation
    Inventors: Robert J. Hariri, Mohammad A. Heidaran, Stephen Jasko, Lin Kang, Eric Law, Ajai Pal, Bhavani Stout, Vanessa Voskinarian-Berse, Andrew Zeitlin, Xiaokui Zhang
  • Publication number: 20160287635
    Abstract: Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells.
    Type: Application
    Filed: November 16, 2015
    Publication date: October 6, 2016
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Robert J. Hariri, Mohammad A. Heidaran, Lin Kang, Neerav Dilip Padliya, Ajai Pal, Vanessa Voskinarian-Berse, Andrew Zeitlin, Xiaokui Zhang
  • Patent number: 9425555
    Abstract: A plug connector includes a lower terminal module, an upper terminal module and an insulating housing. The lower terminal module includes a lower insulator and a plurality of lower terminals integratedly molded in the lower insulator, each of the lower terminals has a lower contact portion beyond a bottom face of the lower insulator. The upper terminal module is engaged with the lower terminal module, includes an upper insulator and a plurality of upper terminals integratedly molded in the upper insulator, each of the upper terminals has an upper contact portion beyond a top face of the upper insulator. The insulating housing is integratedly molded outside the lower terminal module and the upper terminal module, each lower contact portion is exposed from a bottom face of the insulating housing, each upper contact portion is exposed from a top face of the insulating housing.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: August 23, 2016
    Assignee: CHENG UEI PRECISION INDUSTRY CO., LTD.
    Inventors: Feng-Tian Liu, Lin-Kang Li, Zhi Zhang, Qiu-Xiang Mi
  • Patent number: 9255248
    Abstract: Provided herein are methods of producing erythrocytes from hematopoietic cells, particularly hematopoietic cells from placental perfusate in combination with hematopoietic cells from umbilical cord blood, wherein the method results in accelerated expansion and differentiation of the hematopoietic cells to more efficiently produce administrable erythrocytes. Further provided herein is a bioreactor in which hematopoietic cell expansion and differentiation takes place.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: February 9, 2016
    Assignee: Anthrogenesis Corporation
    Inventors: Stewart Abbot, Lin Kang, Vanessa Voskinarian-Berse, Xiaokui Zhang
  • Publication number: 20150366910
    Abstract: Provided herein are placental perfusate, placental perfusate cells, placenta-derived intermediate natural killer cells, combined natural killer cells from placenta and umbilical cord blood, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, placenta-derived intermediate natural killer cells, and combined natural killer cells and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells. Also provided herein are methods of treating an individual having a tumor or graft-versus-host disease with placental perfusate, placental perfusate-derived cells, natural killer cells from placenta, e.g., from placental perfusate, and/or combined natural killer cells comprising natural killer cells from placenta, e.g., from placental perfusate, and umbilical cord blood.
    Type: Application
    Filed: February 4, 2014
    Publication date: December 24, 2015
    Inventors: Xiaokui ZHANG, Robert J. HARIRI, Vanessa VOSKINARIAN-BERSE, Lin KANG, Eric LAW, Stewart ABBOT
  • Patent number: 9216200
    Abstract: Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells.
    Type: Grant
    Filed: August 13, 2012
    Date of Patent: December 22, 2015
    Assignee: Anthrogenesis Corporation
    Inventors: Robert J. Hariri, Mohammad A. Heidaran, Lin Kang, Neerav Dilip Padliya, Ajai Pal, Vanessa Voskinarian-Berse, Andrew Zeitlin, Xiaokui Zhang
  • Patent number: 9200253
    Abstract: Provided herein are methods of producing erythrocytes from hematopoietic cells, particularly hematopoietic cells from placental perfusate in combination with hematopoietic cells from umbilical cord blood, wherein the method results in accelerated expansion and differentiation of the hematopoietic cells to more efficiently produce administrable erythrocytes. Further provided herein is a bioreactor in which hematopoietic cell expansion and differentiation takes place.
    Type: Grant
    Filed: August 6, 2008
    Date of Patent: December 1, 2015
    Assignee: Anthrogenesis Corporation
    Inventors: Mohammad A. Heidaran, Xiaokui Zhang, Lin Kang, Andrew Zeitlin, Vanessa R. Voskinarian-Berse, Stewart Ernest Abbott
  • Publication number: 20150335523
    Abstract: An intelligent massage bathing system applied for a massage bathing equipment is disclosed herein, which comprises a plurality of attached devices, a massage bathing control unit, an operating panel unit and a master control device. The attached devices includes at least one first attached devices and at least one second attached devices, wherein the at least one first attached devices is configured as at least one slave control device. The master control device establishes a master-slave connection with the at least one slave control device, and commands to directly control the at least one slave control device to actuate relatively to the massage bathing equipment, according to an instruction generated from the operating panel unit.
    Type: Application
    Filed: May 26, 2015
    Publication date: November 26, 2015
    Inventors: Chi-Lin KANG, Chung-Hsin HSIEH, Chao-Yuan HUANG
  • Publication number: 20150335524
    Abstract: A massage bathing maintenance system suitable for a massage bathing equipment is provided. The system comprises at least one attached device, at least one slave control device, a master control device, and an analyzing unit. The at least one attached device is configured to actuate with regard to the massage bathing equipment. The at least one slave control device comprises a control unit configured to generate and transmit at least one actuating message according to at least one actuating-status of the at least one attached device. The master control device comprise a log-collecting unit configured to record the at least one actuating message of the at least one slave control device into a logs table. The analyzing unit is configured to analyze the at least one actuating message of the logs table so as to determine whether the actuation of at least one attached device is abnormal.
    Type: Application
    Filed: May 26, 2015
    Publication date: November 26, 2015
    Inventors: Chi-Lin KANG, Chung-Hsin HSIEH, Chao-Yuan HUANG
  • Publication number: 20150225697
    Abstract: Provided herein are methods of producing natural killer (NK) cells and NK progenitor cell populations using a two-step expansion and differentiation method. Also provided herein are methods of producing populations of NK cells and NK progenitor cell populations using a three-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation using the NK cells, the NK cell populations, and the NK progenitor cell populations produced by the methods described herein, as well as methods of treating individuals having cancer or a viral infection, comprising administering the NK cells, the NK cell populations, and the NK progenitor cell populations produced by the methods described herein to an individual having the cancer or viral infection.
    Type: Application
    Filed: August 13, 2013
    Publication date: August 13, 2015
    Applicant: Anthrogenesis Corporation
    Inventors: Eric Law, Lin Kang, Vladimir Jankovic, Xiaokui Zhang, Stewart Abbot, Robert J. Hariri
  • Publication number: 20150072425
    Abstract: Provided herein are methods of producing natural killer cells using a two-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising administering the NK cells produced by the method to an individual having the cancer or viral infection.
    Type: Application
    Filed: November 18, 2014
    Publication date: March 12, 2015
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Robert J. HARIRI, Mohammad A. HEIDARAN, Stephen JASKO, Lin KANG, Eric LAW, Ajai PAL, Bhavani STOUT, Vanessa VOSKINARIAN-BERSE, Andrew ZEITLIN, Xiaokui ZHANG
  • Patent number: 8926964
    Abstract: Provided herein are methods of producing natural killer cells using a two-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising administering the NK cells produced by the method to an individual having the cancer or viral infection.
    Type: Grant
    Filed: July 13, 2011
    Date of Patent: January 6, 2015
    Assignee: Anthrogenesis Corporation
    Inventors: Robert J. Hariri, Mohammad A. Heidaran, Stephen Jasko, Lin Kang, Eric Law, Ajai Pal, Bhavani Stout, Vanessa Voskinarian-Berse, Andrew Zeitlin, Xiaokui Zhang
  • Publication number: 20140256042
    Abstract: Provided herein are methods of producing erythrocytes from hematopoietic cells, particularly hematopoietic cells from placental perfusate in combination with hematopoietic cells from umbilical cord blood, wherein the method results in accelerated expansion and differentiation of the hematopoietic cells to more efficiently produce administrable erythrocytes. Further provided herein is a bioreactor in which hematopoietic cell expansion and differentiation takes place.
    Type: Application
    Filed: October 11, 2013
    Publication date: September 11, 2014
    Applicant: Anthrogenesis Corporation
    Inventors: Stewart Abbot, Lin Kang, Vanessa Voskinarian-Berse, Xiaokui Zhang
  • Publication number: 20140093488
    Abstract: Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells.
    Type: Application
    Filed: August 13, 2012
    Publication date: April 3, 2014
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Robert J. Hariri, Mohammad A. Heidaran, Lin Kang, Neerav Dilip Padliya, Ajai Pal, Vanessa Voskinarian-Berse, Andrew Zeitlin, Xiaokui Zhang
  • Patent number: 8586360
    Abstract: Provided herein are methods of producing erythrocytes from hematopoietic cells, particularly hematopoietic cells from placental perfusate in combination with hematopoietic cells from umbilical cord blood, wherein the method results in accelerated expansion and differentiation of the hematopoietic cells to more efficiently produce administrable erythrocytes. Further provided herein is a bioreactor in which hematopoietic cell expansion and differentiation takes place.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: November 19, 2013
    Assignee: Anthrogenesis Corporation
    Inventors: Stewart Abbot, Lin Kang, Vanessa Voskinarian-Berse, Xiaokui Zhang
  • Patent number: 8263065
    Abstract: Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells.
    Type: Grant
    Filed: September 29, 2008
    Date of Patent: September 11, 2012
    Assignee: Anthrogenesis Corporation
    Inventors: Robert J. Hariri, Mohammad A. Heidaran, Lin Kang, Neerav Dilip Padliya, Ajai Pal, Vanessa Voskinarian-Berse, Andrew Zeitlin, Xiaokui Zhang
  • Patent number: D762178
    Type: Grant
    Filed: January 25, 2015
    Date of Patent: July 26, 2016
    Assignee: CHENG UEI PRECISION INDUSTRY CO., LTD.
    Inventors: Feng-Tian Liu, Lin-Kang Li, Zhi Zhang, Qiu-Xiang Mi